Search

everythinglearnresearchcommunity

for

Search:↓

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Folliculin slows hair growth, and blocking it might help treat hair loss.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

Tofacitinib helped a woman regrow hair with no major side effects.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Over-the-counter hair growth products may cause frontal fibrosing alopecia due to allergens.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Avoiding certain allergens in personal care products may improve symptoms for some patients with lichen planopilaris or frontal fibrosing alopecia.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Facial care products are not linked to causing frontal fibrosing alopecia.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.